Table I.

Characteristics of the Study Sample (N=114)

Characteristics	Type 1	Type 2	Total
	(n = 97)	(n = 17)	(n = 114)
Sociodemographic factors
Age, years (M ± SD)	12.2 ± 3.5	15.1 ± 1.9	12.6 ± 3.5
Child’s sex (female)	52 (54.2%)	6 (33.3%)	57 (50.0%)
Participating caregiver type
Mother	83 (86.5%)	13 (72.2%)	96 (84.2%)
Father	10 (10.4%)	4 (22.2%)	14 (12.3%)
Other	3 (3.1%)	1 (5.6%)	4 (3.5%)
Child’s race/ethnicity
Non-Hispanic, White	53 (54.6%)	0 (0.0%)	53 (46.5%)
Non-Hispanic, Black	23 (23.7%)	14 (82.3%)	37 (32.4%)
Hispanic	15 (15.5%)	2 (11.8%)	17 (14.9%)
Non-Hispanic, Asian	2 (2.1%)	0 (0.0%)	2 (1.8%)
Non-Hispanic, Multiracial	3 (3.1%)	0 (0.0%)	3 (2.6%)
Other (Not Identified)	1 (1.0%)	1 (5.9%)	2 (1.8%)
Household income (n = 90)
<$10,000	2 (2.1%)	4 (22.2%)	6 (5.3%)
$10,000–$29,999	10 (10.4%)	3 (16.7%)	13 (11.4%)
$30,000–$49,999	17 (17.7%)	2 (11.1%)	19 (16.7%)
$50,000–$69,999	5 (5.2%)	1 (5.6%)	6 (5.3%)
$70,000–$89,999	11 (11.5%)	1 (5.6%)	12 (10.5%)
$90,000–$109,000	6 (6.3%)	0 (0.0%)	6 (5.3%)
$110,000 or more	28 (29.2%)	0 (0.0%)	28 (24.6%)
Clinical factors
Duration, months (M ± SD)	50.8 ± 42.8)	23.4 ± 28.3	46.4 ± 41.9
Prescribed Insulin Regimen
Injection	33 (34.4%)	13 (72.2%)	46 (40.4%)
Pump	63 (65.6%)	0 (0.0%)	63 (55.3%)
No insulin		5 (27.8%)	5 (4.4%)
Prescribed metformin		14 (77.8%)	14 (12.3%)
Continuous glucose monitor	56 (58.3%)	0 (0.0%)	56 (49.1%)
HbA1c, % (M ± SD)	8.4 ± 1.9	8.3 ± 2.7	8.4 ± 2.1
CEFIS composites (M ± SD)
Exposure	8.2 ± 3.4	7.4 ± 4.9	8.1 ± 3.7
Impact	2.6 ± 0.7	2.2 ± 1.1	2.5 ± 0.7
Caregiver distress	5.8 ± 2.4	5.7 ± 2.7	5.8 ± 2.4
Child distress	5.1 ± 2.7	5.1 ± 2.9	5.1 ± 2.7

Note. CEFIS = COVID-19 Exposure and Family Impact Scales.